U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. 2018 PDA/FDA Joint Regulatory Conference -
  1. News & Events for Human Drugs

Meeting | In Person

Event Title
2018 PDA/FDA Joint Regulatory Conference

Theme:

Putting Patients First: Ensuring Innovation, Quality, Compliance, and Supply in an Evolving Environment
 

Background

This year marks the 27th year of the joint PDA/FDA conference. The conference will include several plenary sessions, and an extensive selection of breakfast and breakout sessions. The breakout sessions are comprised of three multi-day tracks that focus on assuring reliable manufacturing, quality, and supply, and promoting innovation. Highlights include:  

  • Lifecycle Management and Innovation: Hot topics regarding drug application submissions, post-approval changes (ICH Q12), aging facilities, process validation, combination products, and quality risk management.  
  • Quality and Compliance: Aseptic processing and EU Annex I; latest FDA inspection findings; compliance/enforcement trends; quality trending; effective quality systems; and consent decree lessons learned.
  • Supply Chain: Effective audit programs, shortage prevention and disaster recovery, contract manufacturing oversight, ingredient supplier relationships; and innovative product challenges (cell and gene therapies). 

Location:

Renaissance Washington, D.C.

Dates:

September 24 – 26, 2018 

Technical Topics

The agenda includes more than 50 industry and regulatory experts covering extensive technical content on the above topics as well as quality culture, data integrity, manufacturing innovation, effective training, isolators and restricted access barrier systems, large volume parenteral manufacturing, water systems, container-closure integrity, pharmacy outsourcers, and much more.

Objectives

  • Learn about current FDA priorities from all medical product centers and the Office of Regulatory Affairs. Also, hear updates from European regulators, who will discuss their latest initiatives and collaborative activities.
  • Focus on practical lessons learned through real-life industry case studies.
  • Discuss factors affecting the quality and dependability of the supply chain, and the benefits of manufacturing modernization.

Register

Visit PDA’s event registration page for more information and to register.

Back to Top